Ming-YeeLin

Associate

Tokyo + 81.3.6800.1873

Connect:

Share

Ming-Yee Lin assists public and private companies on cross-border M&A, divestitures, and other corporate law matters. Ming-Yee has supported Japanese and international clients in various industries, including renewable energy, grain, pharmaceuticals, automotive, and technology.

Ming-Yee started her career at an international law firm in California, where she advised clients in real estate financings, property acquisitions, and mergers across the United States and abroad.

Experience

  • Sanken Electric enters into share repurchase agreement with AllegroJones Day represented Sanken Electric Co., Ltd. in connection with its $897.9 million sale of Common Stock of Allegro MicroSystems, Inc.
  • Sumitomo completes sale of $648 million of Common Shares of Roivant Sciences Ltd.Jones Day represented Sumitomo Pharma Co., Ltd. in connection with its privately negotiated sale of $648 million of Common Shares of Roivant Sciences Ltd.
  • Electrolux acquires Tosei CorporationJones Day advised Electrolux Professional Group, a Swedish professional appliance manufacturing company operating globally, in connection with its acquisition of Tosei Corporation from Marunouchi Global Fund II and Marunouchi Capital Fund II, both related to Mitsubishi Corporation, for approximately SEK 1,650 million (JPY 23.25 billion) on a cash and debt free basis.
  • Chevron and MOECO agree to explore advanced closed loop geothermal pilot in Hokkaido, JapanJones Day advised Chevron New Energies on its agreement with Mitsui Oil Exploration Co., Ltd (MOECO) to proceed with the pilot testing of advanced geothermal technology, specifically advanced closed loop (ACL) technology.
  • DIC acquires photoresist polymers manufacturer PCAS CanadaJones Day advised DIC Corporation, a Japanese chemicals group operating globally in over 60 countries, in connection with its acquisition of Quebec-based PCAS Canada Inc., a company that manufactures and sells polymers used in photoresists for semiconductor photolithography, from PCAS S.A., a French company.
  • Marelli Group first-ever use of simplified rehabilitation proceedings in Japan to cram-down creditorsJones Day represented Marelli Holdings Co., Ltd. in the restructuring of its US$7 billion senior debt facilities, which included the coordination and implementation of a sponsor selection process, an out-of-court Turnaround ADR process, and the first-ever use of simplified rehabilitation proceedings in Japan to cram-down creditors, and the subsequent implementation and documentation of its restructured financing arrangements across sixteen different jurisdictions outside Japan.
  • Alternate investment firm obtains $100 million secured facilitiesJones Day advised a leading alternative investment firm in connection with a $100 million secured holdco back leverage facility secured against its interests in certain portfolio companies.
  • Marubeni sells global grain business of Gavilon Agriculture InvestmentJones Day advised Marubeni Corporation in the sale of the global grain business of Gavilon Agriculture Investment, Inc. to Viterra Limited, following a reorganization of Gavilon’s structure.
  • MassMutual sells remaining shares of Nippon Wealth Life Insurance to Nippon LifeJones Day advised Massachusetts Mutual Life Insurance Company and MassMutual International LLC in the sale of MassMutual International's 14.9% interest in Nippon Wealth Life Insurance Company (Nippon Wealth) to Nippon Life Insurance Company.
    • View All

    July 2024 White Paper

    APAC ESG Update | Spring Quarter 2024

    May 2024 Commentary

    Hydrogen Supply and Utilization Promotion Bill: Supporting Low-carbon Hydrogen and Derivatives in Japan

    February 2024 White Paper

    APAC ESG Update | Winter Quarter 2023–24

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.